Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL17201556

O=C(O)C(F)(F)F.O=C(O)c1ncc(-c2cnc(C(F)(F)F)nc2)s1

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 9/20 0.37
HDAC4 P56524 1/20 0.37
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
HDAC1 Q13547 6/20 0.36
CSNK2A1 P68400 1/20 0.35
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
DGAT1 O75907 1/20 0.32
CDK5 Q00535 1/20 0.32
CDK5R1 Q15078 1/20 0.32
ULK1 O75385 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
ERCC5 P28715 1/20 0.31
FEN1 P39748 1/20 0.31
KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL17201525 0.85 HDAC6 (0.37) HDAC6HDAC4CTSSCTSKHDAC1
SCHEMBL17201559 0.78 CTSS (0.35) HDAC6HDAC4CTSSCTSKHDAC1
SCHEMBL17201583 0.75 ALDH1A1 (0.35) HDAC6CTSSCTSKHDAC1ALDH1A1
Trifluoroacetic Acid SCHEMBL17204972 0.75 KDM4E (0.39) HDAC6HDAC4CTSSCTSKHDAC1
SCHEMBL17201499 0.74 CSNK2A1 (0.40) HDAC6CTSSCTSKHDAC1CSNK2A1
Trifluoroacetic Acid SCHEMBL17201561 0.74 KDM4E (0.54) HDAC6HDAC4HDAC1KDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL17201554 0.73 CTSS (0.36) HDAC6HDAC4CTSSCTSKHDAC1
SCHEMBL17212188 0.72 HCAR2 (0.43) HDAC6CTSSCTSKHDAC1CSNK2A1
SCHEMBL24369189 0.72 CYP11B2 (0.41) HDAC6HDAC1KDM4EALDH1A1DGAT1
Trifluoroacetic Acid SCHEMBL17201540 0.72 CDC7 (0.44) HDAC6HDAC4CTSSCTSKHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725459-B2 3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I GRUNENTHAL GMBH (DE) 2017-08-08 US disclosed
EP-3140309-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2017-03-15 EP disclosed
EP-3134414-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES II Grünenthal GmbH (DE) 2017-03-01 EP disclosed
WO-2015161928-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 WO disclosed
WO-2015161924-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES II Grünenthal GmbH (DE) 2015-10-29 WO disclosed
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I CTSK, OPRK1, CAT HDAC6 533/4885HDAC4 1433/4885CTSS 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.